More Articles

Patients and Medical

What patients need right now

Andrew Stone, (Jul 7, 2020)

In the face of massive patient need, there’s plenty pharma can do to help. The crisis is also an opportunity for it to transform the way it works with patients.

The key to digital innovation: The human touch

Andrew Stone, (Jun 30, 2020)

Takeda is building on strong stakeholder relationships it has nurtured patiently over time to co-create solutions during COVID-19

Building the medical affairs organisation of tomorrow

Lucy Fulford, (Jun 15, 2020)

As medical affairs increasingly engages with new stakeholders - HTA bodies, regulators and patient groups - it must upskill and upgrade its data and collaboration capabilities
Patients and Medical

The emerging patient-centricity landscape in Japan

Lucy Fulford, (Jun 9, 2020)

Change is happening in patient engagement as Japan's pharma pioneers begin to lay strong foundations for a richer future

Digital success doesn’t start with the tech

Andrew Stone, (May 28, 2020)

Pharma’s first enterprise Chief Data Officer sits down with Roivant’s Chief Digital Officer to point out where we’ve all been going wrong

Seizing the moment in digital

Katie Osborne, (May 28, 2020)

This is the moment to accelerate digital transformation if only pharma can create the culture and capabilities for such change

Customer centricity in a changed world

Andrew Stone, (Apr 20, 2020)

Pharma’s marketeers are having to rapidly change their approach to customers, field force roles and digital in the midst of the pandemic
Access and Evidence

A burning desire to make a difference for patients

Andrew Stone, (Apr 19, 2020)

Annexus Health, eyeforpharma’s 2020 Health Start-up winner is on a mission for patients

Breaking new ground in healthcare data

Andrew Stone, (Apr 16, 2020)

Pharma should team up with HCPs, regulators and health ministries to create harmonised, interoperable health records and so drive cheaper, faster insights
Patients and Medical

Building a bridge to a COVID-19 vaccine

Andrew Stone, (Apr 15, 2020)

Regeneron shares its latest progress on therapies for the pandemic at eyeforpharma Philadelphia virtual